ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 308847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 308847; 2) Community: the network communities that were significantly associated with the response to NSC 308847; 3) Molecule: the relationships between components within communities and NSC 308847; 4) MDR: the compounds that were significantly associated with the NSC 308847.

NSC Compound Enrichment Correlation
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0446159312763235 0.074149279
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0446159312763235 0.03463362
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0446159312763235 -0.0029000439
NSC 132483 Aminopterin Derivative 0.0459335986102865 0.51039697
NSC 145668 Cyclocytidine hydrochloride 0.0459335986102865 0.55812937
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0459335986102865 0.41845512
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.0459335986102865 0.54057792
NSC 329261 Null 0.0459335986102865 0.12954332
NSC 606172 Camptothecin Derivative 0.0459335986102865 0.43513984
NSC 618939 Camptothecin Derivative 0.0459335986102865 0.47407474
Total:60  Current:50    [First] [Prev] [Next] [Last]